Hematopathology is an ever changing discipline.  Using technologies such as fluorescence in situ hybridization (FISH) and next generation sequencing, researchers are continually discovering new gene abnormalities important for the prognosis and therapy of leukemia and lymphoma. 

Our commitment is to keep up to date on these emerging changes and to provide you established, clinically proven testing options to fit the needs of your practice.

Testing is discussed with the ordering pathologist or clinician. This assures optimal integration of the results and overall better treatment planning.